61 records, the earliest from 10 May 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
61 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Purpose | Notes |
|---|---|---|
| 10 Aug 2026 | Financial Results | JUBLPHARMA : 10-Aug-2026 : The Company has informed the Exchange that a Board meeting to be held on August 07, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 10, 2026, To consider and approve the financial results for the period ended Jun 30, 2026 |
| 7 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 22 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 6 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 31 Oct 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 29 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 16 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
| 31 Jan 2025 | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
| 25 Oct 2024 | Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| 19 Jul 2024 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
